Safety and Immunogenicity Study of 2019-nCov Vaccine (mRNA-1273) to Treat Novel Coronavirus

Condition:   Corona Virus Infection Intervention:   Biological: mRNA-1273 Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting

Source: ClinicalTrials.gov - February 25, 2020 Category: Research Source Type: clinical trials